JP Morgan Chase
STDY

JP Morgan Chase’s SteadyMed Ltd STDY Stock Holding History

JP Morgan Chase’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,981
Closed -$19K – 5343
2017
Q2 		$19K Buy
+2,981
New +$20.3K ﹤0.01% 4553

Other funds holding STDY

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

JP Morgan Chase's STDY Position: Q3 2017 in Review

JP Morgan Chase sold out of SteadyMed Ltd (STDY) in Q3 2017, closing a stake of 2,981 shares — an estimated $19K sold.

JP Morgan Chase first reported a position in STDY in Q2 2017 and held it in 1 quarter. The position peaked at $19K in Q2 2017. 26 funds tracked by Wall St. Rank hold STDY as of Q3 2017.

  • JP Morgan Chase reported no remaining SteadyMed Ltd position as of Q3 2017 after selling out during the quarter.
  • JP Morgan Chase sold 2,981 SteadyMed Ltd shares in Q3 2017, an estimated $19K.
  • JP Morgan Chase first reported a position in SteadyMed Ltd in Q2 2017 and held it in 1 quarter.
  • JP Morgan Chase's SteadyMed Ltd position peaked at $19K in Q2 2017.
  • 26 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2017.

Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.